Quinn Opportunity Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Quinn Opportunity Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-31,000	Closed	-$6.72M	–	263
2021 Q1	$6.72M	Buy	+31,000	New	+$5.83M	0.43%	53

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Quinn Opportunity Partners's GWPH Position: Q2 2021 in Review

Quinn Opportunity Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 31,000 shares — an estimated $6.72M sold.

Quinn Opportunity Partners first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $6.72M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Quinn Opportunity Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Quinn Opportunity Partners sold 31,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $6.72M.
Quinn Opportunity Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Quinn Opportunity Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6.72M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Quinn Opportunity Partners's 13F filing for Q2 2021, filed 16 Aug 2021.